Elevation Oncology Inc. (NASDAQ: ELEV) Stock Information | RedChip

Elevation Oncology Inc. (NASDAQ: ELEV) Listen to this Section


$0.71
-0.0102 ( -1.41% ) 539.1K

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Market Data


Open


$0.71

Previous close


$0.72

Volume


539.1K

Market cap


$42.01M

Day range


$0.71 - $0.74

52 week range


$0.36 - $5.83

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
3 Insider transactions 2 Jan 22, 2024
8-k 8K-related 13 Jan 05, 2024
4 Insider transactions 1 Dec 19, 2023
8-k 8K-related 14 Nov 02, 2023
10-q Quarterly Reports 75 Nov 02, 2023
8-k 8K-related 13 Sep 22, 2023
4 Insider transactions 1 Sep 19, 2023
4 Insider transactions 1 Sep 05, 2023
8-k 8K-related 13 Aug 16, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.